| Human |
hsa_circ_UBR5 |
- |
circUBR5 |
lupus nephritis |
UBR5 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_UBR5 |
hsa_circ_0001818 |
hsa_circRNA_104670 |
bacterial infectious disease with sepsis |
UBR5 |
hsa-miR-17-3p, hsa-miR-433-3p, hsa-miR-367-5p, hsa-miR-335-3p, hsa-miR-642a-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_UBR5 |
hsa_circ_0001819 |
circUBR5 |
signet ring cell gastric adenocarcinoma |
UBR5 |
hsa-miR-1208 |
Q
H
S
| UP |
More |
| Human |
hsa_circ_UBR5 |
hsa_circ_0005070 |
- |
juvenile spondyloarthropathy |
UBR5 |
hsa-miR-1225-3p, hsa-miR-1825, hsa-miR-193a-5p, hsa-miR-300, hsa-miR-485-3p, hsa-miR-548c-5p, hsa-miR-628-3p |
M
| DN |
More |
| Human |
hsa_circ_UBR5 |
hsa_circ_0001818 |
hsa_circRNA_104670 |
bacterial infectious disease with sepsis |
UBR5 |
miR-17-3p, miR-433-3p, miR-642a-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_UBR5 |
hsa_circ_0085207 |
circ-UBR5 |
lung adenocarcinoma |
UBR5 |
- |
Q
H
M
| UP |
More |
| Human |
hsa_circ_UBR5 |
- |
circ-UBR5 |
non-small cell lung carcinoma |
UBR5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_UBR5 |
hsa_circ_0001819 |
circUBR5 |
triple-negative breast carcinoma |
UBR5 |
miR-1179 |
Q
| UP |
More |
| Human |
hsa_circ_UBR5 |
hsa_circ_0001818 |
circ_0001818 / circRNA_104670 |
acute kidney injury |
UBR5 |
miR-136-5p |
Q
| UP |
More |